MoneyWorks4Me

Ajanta Pharma - Quaterly Results

31 Oct 2023 Evaluate
The September 2023 quarter revenue stood at Rs. 9451.80 millions, up 12.89% as compared to Rs. 8372.30 millions during the corresponding quarter last year.An average growth of 27.02% was recorded for the quarter ended September 2023 to Rs. 2123.60  millions from Rs. 1671.80 millions.Operating profit surged to 3258.10 millions from the corresponding previous quarter of 2391.00 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 9451.80 8372.30 12.89 19597.60 16875.20 16.13 34112.70 31406.40 8.62
Other Income 521.60 783.70 -33.44 836.20 1137.90 -26.51 1327.50 1397.30 -5.00
PBIDT 3258.10 2391.00 36.27 6341.70 4608.30 37.61 8320.30 10306.20 -19.27
Interest 22.70 7.10 219.72 30.20 13.40 125.37 52.30 91.20 -42.65
PBDT 3235.40 2383.90 35.72 6311.50 4594.90 37.36 8268.00 10215.00 -19.06
Depreciation 330.40 318.00 3.90 652.80 625.50 4.36 1269.50 1209.60 4.95
PBT 2905.00 2065.90 40.62 5658.70 3969.40 42.56 6998.50 9005.40 -22.29
TAX 781.40 394.10 98.27 1414.70 793.90 78.20 1411.30 1806.80 -21.89
Deferred Tax 29.10 -61.10 -147.63 56.60 -79.40 -171.28 -29.30 95.10 -130.81
PAT 2123.60 1671.80 27.02 4244.00 3175.50 33.65 5587.20 7198.60 -22.38
Equity 252.70 257.10 -1.71 252.70 257.10 -1.71 252.70 171.70 47.18
PBIDTM(%) 34.47 28.56 20.70 32.36 27.31 18.50 24.39 32.82 -25.67
Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..